Artificial chemical receptor developed to assist in T cell engineering - Drug Target Review
Artificial chemical receptor developed to assist in T cell engineering Drug Target ReviewEngineered T cell immunotherapy (such as CAR-T and TCR-T therapy), could potentially be used as a therapeutic strategy for tumour treatment.